Tech Spotlight: The Future of Antibody Screening in Drug Discovery and Diagnostic Innovation
Fill out the form below and we'll send your colleague an invitation to the "Tech Spotlight: The Future of Antibody Screening in Drug Discovery and Diagnostic Innovation" event.
Antibodies remain at the heart of modern therapeutics and diagnostics and the technologies driving their discovery are evolving rapidly. In this webinar, we’ll explore the latest innovations in antibody screening, including next-generation screening, high-throughput platforms and machine learning tools that are accelerating the pace of discovery and development.
In this webinar, Dr. Katilin Johnson will introduce biofloating – a novel suspension-based antibody discovery platform developed to overcome limitations in targeting transmembrane proteins. Developed in the Spangler lab, this platform enables the screening of antibody libraries directly against multipass transmembrane targets expressed on cell surfaces.
In addition, leading experts will join us to highlight innovative screening platforms and assay technologies that are transforming and accelerating antibody discovery and development.
By attending this webinar you’ll learn:
- How the biofloating platform enables the discovery of high-affinity antibodies against challenging transmembrane protein targets
- How high-throughput cytometry is being used to accelerate antibody profiling in scalable plate-based formats
- How TR-FRET assays are facilitating sensitive, low-background detection of molecular interactions in antibody screening
You can withdraw your consent at any time with effect for the future. This does not affect the lawfulness of the processing up to the time of withdrawal.
Further information on the processing of personal data can be found in the Sartorius Privacy Notice.
Technology Networks may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
